A detailed history of Quent Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Quent Capital, LLC holds 2,512 shares of BSX stock, worth $227,160. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,512
Previous 2,778 9.58%
Holding current value
$227,160
Previous $213,000 1.41%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$72.96 - $84.0 $19,407 - $22,344
-266 Reduced 9.58%
2,512 $210,000
Q2 2024

Jul 08, 2024

BUY
$67.33 - $77.71 $3,501 - $4,040
52 Added 1.91%
2,778 $213,000
Q1 2024

May 02, 2024

BUY
$57.6 - $68.62 $5,068 - $6,038
88 Added 3.34%
2,726 $186,000
Q4 2023

Jun 14, 2024

BUY
$48.64 - $57.81 $1,021 - $1,214
21 Added 0.8%
2,638 $152,000
Q4 2023

Jan 19, 2024

BUY
$48.64 - $57.81 $1,021 - $1,214
21 Added 0.8%
2,638 $152,000
Q3 2023

Jun 14, 2024

BUY
$50.19 - $54.68 $4,818 - $5,249
96 Added 3.81%
2,617 $138,000
Q3 2023

Oct 10, 2023

BUY
$50.19 - $54.68 $4,818 - $5,249
96 Added 3.81%
2,617 $138,000
Q2 2023

Jun 14, 2024

BUY
$49.72 - $54.64 $10,242 - $11,255
206 Added 8.9%
2,521 $136,000
Q2 2023

Jul 10, 2023

BUY
$49.72 - $54.64 $10,242 - $11,255
206 Added 8.9%
2,521 $136,000
Q1 2023

Jun 14, 2024

SELL
$45.09 - $50.03 $18,531 - $20,562
-411 Reduced 15.08%
2,315 $115,000
Q1 2023

Apr 05, 2023

BUY
$45.09 - $50.03 $46,352 - $51,430
1,028 Added 79.88%
2,315 $115,000
Q3 2022

Nov 10, 2022

BUY
$36.71 - $109.66 $1,027 - $3,070
28 Added 2.22%
1,287 $50,000
Q1 2022

May 12, 2022

BUY
$40.9 - $45.1 $17,873 - $19,708
437 Added 53.16%
1,259 $56,000
Q4 2021

Feb 28, 2022

BUY
$38.07 - $44.87 $31,293 - $36,883
822 New
822 $35,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.